Skip to search formSkip to main contentSkip to account menu

ONO2506

Known as: ONO-2506, ono 2506 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Caprylates

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Efeito neuroprotetor da administração de ácido arúndico [ácido (R)-(-)-2-propiloctanóico, ONO-2506] em ratos submetidos à hipóxia-isquemia neonatal
2014
2014
Arundic acid (ONO-2506) inhibits secondary injury and improves motor function in rats with spinal cord injury
2008
2008
ONO-2506 may both prevent and treat epilepsy.
2005
2005
Astrocytic activation and delayed infarct expansion after permanent focal ischemia in rats : part 2 : suppression of astrocytic activation by a novel agent (R)-(-)-2-propyloctanoic acid (ONO-2506…
Highly Cited
2004
Highly Cited
2004
Attenuation of a delayed increase in the extracellular glutamate level in the peri-infarct area following focal cerebral ischemia by a novel agent ONO-2506
Highly Cited
2004
Highly Cited
2004
Arundic acid, an astrocyte-modulating agent, protects dopaminergic neurons against MPTP neurotoxicity in mice
2003
2003
ONO-2506. Ono.
1999
1999
The Effect of ONO-2506 on Permanent Focal Ischemia in Rats
A novel synthetic agent, ONO-2506, which inhibits the production of S-100 protein by cultured astrocytes, was shown to ameliorate… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)